BiotechTube

VWF/FVIII products

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Von Willebrand Disease

Conditions

Von Willebrand Disease

Trial Timeline

Jun 1, 2007 → Feb 1, 2013

NCT ID
NCT00557908

About VWF/FVIII products

VWF/FVIII products is a pre-clinical stage product being developed by CSL for Von Willebrand Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00557908. Target conditions include Von Willebrand Disease.

What happened to similar drugs?

4 of 7 similar drugs in Von Willebrand Disease were approved

Approved (4) Terminated (0) Active (3)
✅Blood coagulation Factor VIII and vWF, humanCSLApproved
✅VoncentoCSLApproved
✅Alphanate SD/HTGrifolsApproved
✅plasma-derived FVIII/VWF concentrateGrifolsApproved
🔄Emicizumab + von Willebrand Factor (VWF) Concentrates + Factor VIII (FVIII) Concentrates + von Willebrand Factor (VWF) and Factor VIII (FVIII) Concentrates + Bypassing AgentsRochePhase 3
🔄BiostateCSLPhase 3
🔄BiostateCSLPhase 3

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00557908Pre-clinicalCompleted

Competing Products

14 competing products in Von Willebrand Disease

See all competitors
ProductCompanyStageHype Score
Von Willebrand Factor Concentrates + Von Willebrand Factor Concentrates and Factor VIII Concentrates + Factor VIII Concentrates + Recombinant Activated Factor VII + Activated Prothrombin Complex ConcentrateRochePre-clinical
33
Emicizumab + von Willebrand Factor (VWF) Concentrates + Factor VIII (FVIII) Concentrates + von Willebrand Factor (VWF) and Factor VIII (FVIII) Concentrates + Bypassing AgentsRochePhase 3
47
Neumega (Oprelvekin, Interleukin 11, IL-11)PfizerPhase 2
27
Oprelvekin, Interleukin 11, IL-11PfizerPhase 2
35
recombinant interleukin-11 + recombinant interleukin-11 + recombinant interleukin-11PfizerPhase 2
35
efanesoctocog alfa (BIVV001)SanofiPhase 1
29
BiostateCSLPhase 3
40
Voncento®CSLPre-clinical
26
Blood coagulation Factor VIII and vWF, humanCSLApproved
43
Biostate® + Biostate®CSLPhase 2/3
38
BiostateCSLPhase 3
40
VoncentoCSLApproved
43
Alphanate SD/HTGrifolsApproved
44
plasma-derived FVIII/VWF concentrateGrifolsApproved
47